Actively Recruiting
Evaluation of the Quality of Life of Patients With Bronchiectasis Using an Oscillating Positive Expiratory Pressure Device
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2026-01-23
60
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
C
Centre Hospitalier Universitaire, Amiens
Lead Sponsor
H
Hôpital Armand Trousseau
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are investigating the quality of life and treatment adherence in children and adults with bronchiectasis (DDB) who have not previously used an oscillating positive expiratory pressure (OPEP) device. The goal is to understand how using an oscillating PEP affects their daily lives. This study is interventional and involves assessing patients before and after they begin using the device. Participants will complete quality of life questionnaires tailored by age group: children aged 8 to 13, adolescents aged 14 to 17, and adults. Parents of children aged 8 to 13 will also fill out questionnaires. After several months of using the oscillating PEP, patients will receive a satisfaction and adherence questionnaire to evaluate their experience. The study follows participants over 18 months to monitor changes. During the study, participants will attend regular follow-up consultations to ensure clinical stability. Researchers will track quality of life changes and treatment adherence through questionnaires. The main outcome measured is the variation in patient quality of life before and after starting the OPEP device. The study aims to collect data over an 18-month period, allowing for long-term monitoring of effects and compliance.
CONDITIONS
Brief Title
Evaluation of the Quality of Life of Patients With DBB With the Installation of OPEP
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 8 years and older and adults with bronchiectasis (DDB) who do not currently use an oscillating positive expiratory pressure (OPEP) device
- Participants must be clinically stable
- Participants must be under regular follow-up consultations
You will not qualify if you...
- Children under 8 years of age
- Patients currently using an OPEP device
- Patients in an acute exacerbation phase of bronchiectasis
- Patients not under regular consultation
- Patients with severe, uncontrolled co-morbidities
- Patients with cognitive or psychiatric disorders preventing adherence to the study protocol
- Patients participating in another clinical study that could interfere with this study's results
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 18 months
Participants use the oscillating positive expiratory pressure (OPEP) device and complete quality of life and satisfaction adherence questionnaires over the course of the study.
Questionnaires completed at baseline and after several months of OPEP use
Trial Site Locations
Total: 1 location
1
CHU Amiens-Picardie
Amiens, France, 80054
Actively Recruiting
Research Team
T
Thomas PINTO, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here